Search Results - "van de Giessen, Elsmarieke M"

Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma by Henssen, Dylan, Leijten, Lars, Meijer, Frederick J A, van der Kolk, Anja, Arens, Anne I J, Ter Laan, Mark, Smeenk, Robert J, Gijtenbeek, Anja, van de Giessen, Elsmarieke M, Tolboom, Nelleke, Oprea-Lager, Daniela E, Smits, Marion, Nagarajah, James

“…The post-treatment imaging surveillance of gliomas is challenged by distinguishing tumor progression (TP) from treatment-related abnormalities (TRA)…”
Get full text

Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case–control study (VeCosCO) by Verveen, Anouk, Verfaillie, Sander C J, Visser, Denise, Csorba, Irene, Coomans, Emma M, Koch, Dook W, Appelman, Brent, Barkhof, Frederik, Boellaard, Ronald, de Bree, Godelieve, van de Giessen, Elsmarieke M, Golla, Sandeep, van Heugten, Caroline M, Horn, Janneke, Hulst, Hanneke E, de Jong, Menno D, Kuut, Tanja A, van der Maaden, Tessa, van Os, Yvonne M G, Prins, Maria, Slooter, Arjen J C, Visser-Meily, Johanna M A, van Vugt, Michele, van den Wijngaard, Cees C, Nieuwkerk, P T, Knoop, H, Tolboom, Nelleke, van Berckel, Bart N M

“…IntroductionThe risk factors for persistent fatigue and cognitive complaints after infection with SARS-CoV-2 and the underlying pathophysiology are largely…”
Get full text

Longitudinal Assessment of Retinal Microvasculature in Preclinical Alzheimer's Disease by Curro, Katie R, van Nispen, Ruth M A, den Braber, Anouk, van de Giessen, Elsmarieke M, van de Kreeke, Jacoba A, Tan, H Stevie, Visser, Pieter-Jelle, Bouwman, Femke H, Verbraak, Frank D

“…To investigate if changes in vessel density (VD) and the foveal avascular zone (FAZ) occur in the preclinical phase of Alzheimer's disease (pAD) over time…”
Get full text

Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups by Dubbelman, Mark A, Hendriksen, Heleen M A, Harrison, John E, Vijverberg, Everard G B, Prins, Niels D, Kroeze, Lior A, Ottenhoff, Lois, Van Leeuwenstijn, Mardou M S S A, Verberk, Inge M W, Teunissen, Charlotte E, van de Giessen, Elsmarieke M, Van Harten, Argonde C, Van Der Flier, Wiesje M, Sikkes, Sietske A M

“…It is unclear to what extent cognitive outcome measures are sensitive to capture decline in Alzheimer disease (AD) prevention trials. We aimed to analyze the…”
Get full text

Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice by Verberk, Inge M. W., Jutte, Jolien, Kingma, Maurice Y., Vigneswaran, Sinthujah, Gouda, Mariam M. T. E. E., Engelen, Marie‐Paule, Alcolea, Daniel, Arranz, Javier, Fortea, Juan, Lleó, Alberto, Chevalier, Claire, Marizzoni, Moira, Giessen, Elsmarieke M., Lemstra, Afina W., Pijnenburg, Yolande A. L., Flier, Wiesje M., den Braber, Anouk, Wilson, David, Schut, Martijn C., Harten, Argonde C., Teunissen, Charlotte E.

“…INTRODUCTION We developed a multimarker blood test result interpretation tool for the clinical dementia practice, including phosphorylated (P‐)tau181,…”
Get full text

Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer’s disease (DEBBIE-AD): a prospective observational multicohort study protocol by Padrela, Beatriz, Mahroo, Amnah, Tee, Mervin, Sneve, Markus H, Moyaert, Paulien, Geier, Oliver, Kuijer, Joost P A, Beun, Soetkin, Nordhøy, Wibeke, Zhu, Yufei David, Buck, Mareike A, Hoinkiss, Daniel C, Konstandin, Simon, Huber, Jörn, Wiersinga, Julia, Rikken, Roos, de Leeuw, Diederick, Grydeland, Håkon, Tippett, Lynette, Cawston, Erin E, Ozturk-Isik, Esin, Linn, Jennifer, Brandt, Moritz, Tijms, Betty M, van de Giessen, Elsmarieke M, Muller, Majon, Fjell, Anders, Walhovd, Kristine, Bjørnerud, Atle, Pålhaugen, Lene, Selnes, Per, Clement, Patricia, Achten, Eric, Anazodo, Udunna, Barkhof, Frederik, Hilal, Saima, Fladby, Tormod, Eickel, Klaus, Morgan, Catherine, Thomas, David L, Petr, Jan, Günther, Matthias, Mutsaerts, Henk J M M

“…IntroductionLoss of blood-brain barrier (BBB) integrity is hypothesised to be one of the earliest microvascular signs of Alzheimer’s disease (AD). Existing BBB…”
Get full text

Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss by van der Zwaal, Esther M, de Weijer, Barbara A, van de Giessen, Elsmarieke M, Janssen, Ignace, Berends, Frits J, van de Laar, Arnold, Ackermans, Mariette T, Fliers, Eric, la Fleur, Susanne E, Booij, Jan, Serlie, Mireille J

“…Abstract In several studies reduced striatal dopamine D2/3 receptor (D2/3 R) availability was reported in obese subjects compared to lean controls. Whether…”
Get full text

Imaging of serotonin transporters with [123I]FP-CIT SPECT in the human hypothalamus by Borgers, Anke J, Alkemade, Anneke, Van de Giessen, Elsmarieke M, Drent, Madeleine L, Booij, Jan, Bisschop, Peter H, Fliers, Eric

“…Background Serotonergic neurons in the rodent hypothalamus are implicated in key neuroendocrine and metabolic functions, including circadian rhythmicity…”
Get full text

Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders by Koenders, Laura, MSc, Machielsen, Marise W.J., MD, MSc, van der Meer, Floor J., MSc, van Gasselt, Angelique C.M., MSc, Meijer, Carin J., PhD, van den Brink, Wim, MD, PhD, Koeter, Maarten W.J., PhD, Cousijn, Janna, PhD, Rive, Maaike M., MD, MSc, Schene, Aart H., MD, PhD, Huyser, Chaim, MD, PhD, de Kwaasteniet, Bart P., MD, MSc, Veltman, Dick J., MD, PhD, de Haan, Lieuwe, MD, PhD, Caan, Matthan W.A., PhD, van de Giessen, Elsmarieke, MD, PhD, Braber, Anouk den, PhD, van ‘t Ent, Dennis, PhD

“…Background Schizophrenia is highly comorbid with cannabis use disorders (CUDs), and this comorbidity is associated with an unfavourable course. Early onset or…”
Get full text